ABSTRACT

Bisoprolol is a beta-blocker protocol was developed and validated for quantification of bisoprolol in human plasma. Bio-availability studies are analysed with the human plasma bind with bisoprolol. In assay methods are can be used to determine the presence of a specific proteinbinding are occur approximately 30% of serum within 2 to 4 hrs in renal function. The mass transition pairs of m/z 326 > 116 and 326.4 > 268.4 mass spectrometery method are determine the bisoprolol and internal examination. During method validation over the range of 0.4-100 ng/mL. Linearity, accuracy, precision, recovery, matrix effect, dilution test and stability are analysed. It is used to determine FTIR, HPTLC, LCMS, HPLC examine in the form of biological fluids. LCMS methods are more sensitive, specific and reproducible, suitable to determine the bisoprolol concentration. Keywords: Bisoprolol, FTIR, HPTLC, LCMS, HPLC
Publication date: 01/08/2022

https://ijbpas.com/pdf/2022/August/MS_IJBPAS_2022_6320.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.8.6320